Prevalence of skin allograft discards as a result of serological and molecular microbiological screening in a regional skin bank in Italy

Burns

Volumn 32, Issue 3, 2006, Pages 348-351

  Pianigiani, Elisa ^a   Risulo, Massimiliano ^a   Ierardi, Francesca ^a   Sbano, Paolo ^a   Andreassi, Lucio ^a   Fimiani, Michele ^a   Caudai, Cinzia ^a   Valensin, Pier Egisto ^a   Zazzi, Maurizio ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

Serological screening; Skin allograft; Skin banking

Indexed keywords

ADULT; ARTICLE; CADAVER DONOR; COST BENEFIT ANALYSIS; CYTOMEGALOVIRUS; DONOR SELECTION; FEMALE; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T CELL LEUKEMIA VIRUS; HUMAN TISSUE; ITALY; MALE; MICROBIOLOGY; POLYMERASE CHAIN REACTION; SCREENING; SEROLOGY; SKIN ALLOGRAFT; TREPONEMA PALLIDUM; VIRUS DETECTION;

CADAVER; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; ORGAN PRESERVATION; POLYMERASE CHAIN REACTION; SKIN; SKIN TRANSPLANTATION; TISSUE BANKS; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS; TREPONEMAL INFECTIONS; VIRUS DISEASES;

EID: 33645050112     PISSN: 03054179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.burns.2005.10.005     Document Type: Article

References (25)

1. M.K. Obeng, R.L. McCauley, J.R. Barnett, K. Sheridan, and S.S. Schutzler Cadaveric allograft discards as a result of positive skin cultures Burns 27 2001 267 271
2. J.R. Barnett, R.L. McCauley, S. Schutzler, K. Sheridan, and J.P. Heggers Cadaver donor discards secondary to serology J Burn Care Rehabil 2 2001 124 127
3. N. Grossman, and E. Arbel Skin donors positive for HBV core antibodies-to bank or not to bank? An overview from a regional tissue bank Cell Tissue Bank 2 2001 249 254
4. P. See, T.T. Phan, C. Song, and S.T. Lee Our clinical experience using cryopreserved cadaveric allograft for the management of severe bums Cell Tissue Bank 2 2001 113 117
5. J. Van Baare, E.E. Ligtvoet, and E. Middelkoop Microbiological evaluation of glycerolised cadaveric donor skin Transplantation 7 1998 966 970
6. J. Van Baare, P.U. Cameron, and N. Vardaxis Comparison of glycerol preservation with cryopreservation method on HIV-1 inactivation J Burn Care Rehabil 6 1998 494 500
7. J.P. Pirnay, C. Vandenvelde, L. Duinslaeger, P. Reper, and A. Vanderkelen HIV transmission by transplantation of allograft skin: a review of the literature Burns 23 1997 1 5
8. J.L. Gala, A.T. Vandenbroucke, B. Vandercam, J.P. Pirnay, M. Delferriere, and G. Burtonboy HIV-1 detection by nested PCR and viral culture in fresh or cryopreserved postmortem skin: potential implications for skin handling and allografting J Clin Pathol 50 1997 481 484
9. J.A. Clarke HIV transmission and skin grafts Lancet 1987 983
10. P.G. Kealy Disease transmission by means of allograft J Burn Care Rehabil 18 1997 S10
11. M.K. Scardino, S. Hwang, C.L. Hanna, M.B. Danneffel-Mandelkorn, and K.R. Wilhelmus The postmortem sociomedical interview Cornea 21 2002 798 802
12. S. Zou, R.Y. Dodd, S.L. Stramer, and D.M. Strong Probability of viremia with HBV, HCV, HIV, and HTLV among tissue donors in the United States N Engl J Med 351 2004 751 759
13. S.L. Stramer, S.A. Glynn, and S.H. Kleinman Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing N Engl J Med 351 2004 760 768
14. F. Najioullah, V. Barlet, and P. Renaudier Failure and success of HIV tests for the prevention of HIV-1 transmission by blood and tissue donations J Med Virol 73 2004 347 349
15. A. Mele, T. Stroffilini, and A.R. Zanetti Hepatitis B in Italy: where we are 10 years after the introduction of mass vaccination J Med Virol 67 2002 440 443
16. J.P. Allain Transfusion risks of yesterday and of today Transfus Clin Biol 10 2003 1 5
17. M.P. Busch Should HBV DANN NAT replace HbsAg and/or anti-HBc screening of blood donors? Transfus Clin Biol 11 2004 26 32
18. A. Heim, D. Wagner, T. Rorhamel, U. Hartmann, J. Flik, and W. Verhagen Evaluation of serological screening of cadaveric sera for donor selection for cornea transplantation J Med Virol 58 1999 291 295
19. L. Blendis, Y. Lurie, and R. Oren Occult HBV infection-both hidden and mysterious Gastroenterology 125 2003 1903 1905
20. E. Rodriguez-Inigo, L. Mariscal, and J. Bartolome Distribution of hepatitis B virus in the liver of chronic haepatitis C patients with occult hepatitis B virus infection J Med Virol 70 2003 570 571
21. S.H. Kleinman, M.C. Kuhns, and D.S. Todd Frequency of HBV DNA detection in US blood donors testing positive for the presence of anti-HBc: implications for transfusion transmission and donor screening Transfusion 43 2003 696 704
22. H.S. Conjeevaran, and A.S. Lok Occult hepatitis B virus infection: a hidden menace Hepatology 34 2001 204 206
23. W.K. Roth, M. Weber, and D. Petersen NAT for HBV and anti-HBc testing increases blood safety Transfusion 42 2002 869 875
24. M. Zazzi, L. Romano, and M. Catucci Low human immunodeficiency virus type 1 (HIV-1) DNA burden as a major cause for failure to detect HIV-1 DNA in clinical specimen by PCR J Clin Microbiol 33 1995 205 208
25. B. Parekh, S. Phillips, T.C. Granade, J. Baggs, D.J. Hu, and R. Respess Impact of HIV type 1 subtype variation on viral RNA quantitation AIDS Res Hum Retroviruses 15 1999 133 142